Bioanalytical strategies to evaluate cisplatin nanodelivery systems: From synthesis to incorporation in individual cells and biological response

This publication has 112 references indexed in Scilit:

• Efficacy and Toxicity of Peritumoral Delivery of Nanoconjugated Cisplatin in an In Vivo Murine Model of Head and Neck Squamous Cell Carcinoma
  JAMA Otolaryngology–Head & Neck Surgery, 2013
• Targeted Delivery of Cisplatin to Lung Cancer Using ScFvEGFR-Heparin-Cisplatin Nanoparticles
  ACS Nano, 2011
• Differential contributory roles of nucleotide excision and homologous recombination repair for enhancing cisplatin sensitivity in human ovarian cancer cells
  Molecular Cancer, 2011
• Pulmonary delivery of cisplatin–hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer
  International Journal of Pharmaceutics, 2010
• Polymer−Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery
  ACS Nano, 2009
• Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting
  Dalton Transactions, 2009
• Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles
  Proceedings of the National Academy of Sciences, 2008
• Intralymphatic Chemotherapy Using a Hyaluronan–Cisplatin Conjugate
  Journal of Surgical Research, 2008
• Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer
  British Journal of Cancer, 2006
• Cisplatin: mode of cytotoxic action and molecular basis of resistance
  Oncogene, 2003